<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for Northamptonshire STP</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for Northamptonshire STP</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=stp+E54000020">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where Northamptonshire STP is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0408010K0&amp;denomIds=4.8.1&amp;selectedTab=summary">Mesuximide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Control of epilepsy</td>
      <td>167273</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.33</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_O3VHKIMtwVVLKdIKFZRIqVAGRINrGXSG"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_O3VHKIMtwVVLKdIKFZRIqVAGRINrGXSG" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0408010K0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Mesuximide 300mg capsules : 1</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023AR&amp;denomIds=6.1.2&amp;selectedTab=summary">Empagliflozin/metformin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4574</td>
      <td>Other antidiabetic drugs</td>
      <td>82853</td>
      <td>0.06</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.47</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_0ipJUAPpSkwABUMJCkHLCIaiKKqREsNN"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_0ipJUAPpSkwABUMJCkHLCIaiKKqREsNN" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 850mg tablets : 106</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 1g tablets : 1796</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARAAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 850mg tablets : 110</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARAAADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 1g tablets : 2545</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 5mg/850mg tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARBBABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 5mg/1000mg tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0601023ARBBADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 12.5mg/1000mg tablets : 6</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1310020E0&amp;denomIds=13.10.2&amp;selectedTab=summary">Bifonazole</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Antifungal preparations</td>
      <td>4633</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.95</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_V0zKNkWllCi2WkZFJRaiogkmGLxUtCWC"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_V0zKNkWllCi2WkZFJRaiogkmGLxUtCWC" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1310020E0AAAAAA&amp;denomIds=13.10.2&amp;selectedTab=summary" target="_blank">Bifonazole 1% cream : 6</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0408010AA&amp;denomIds=4.8.1&amp;selectedTab=summary">Felbamate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Control of epilepsy</td>
      <td>167273</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.94</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_NJAyNoYkFypgE6RIqECpPFiQECMaiEIX"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_NJAyNoYkFypgE6RIqECpPFiQECMaiEIX" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0408010AAAAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Felbamate 600mg tablets : 6</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0407010P0&amp;denomIds=4.7.1&amp;selectedTab=summary">Nefopam hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>12306</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>203904</td>
      <td>0.06</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>4.58</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_SSuJIUqgoTgtQyRBuapSICiQ0BYFRhIh"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAQrklEQVR4nO3deZAmdX3H8fdvd3ZhWS4TQESEFhGIROQIoFGCgCLaoCJHNMVRSkhAIuEwSSuJIUqgoTgtQyRBuapSICiQ0BYFRhIhHAko1xKupZpThIircrnHdP7oXvZhetjtnXmep5/nmfer6lfP8/TTM/Pt3/RT85nfr49QFAWSJEmrMqvtAiRJ0nAwNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJE0mhPmEUFRtftvlDAJDgyRJamSs7QK6IUqyDYFNgbd2tLcABfAi8Ovq8UXgZ8BPgDxP46KVgiVJGkKhKIbv72YVEvYE9qraFlP4NouAH1ftLuDGPI1/3rUiJUnDrZySeLF6tTZF8VKb5QyCoQkNUZJtDhwJ7AdsN+HtB4DHgKc72jPAOLAOsHbH42bADsD2wJod32MZ8O/AVcDVeRr/X6+2RZI0BAwNNQMdGqIkmwXsDXweiFlxDMZC4IeUf+RvytP4uSl87zFga2BH4APAJ4GNqreXATcBlwGX52m8eBqbIUkaRoaGmoEMDVGSzQeOogwLy6cefgb8E3BxnsaP9eBnzgZ2Aw4CDgDeXL31DPB14II8jRd1++dKkgaUoaFmoEJD9Yf7cOAUygMZAf4TOB+4pl//8Vd17A4cC3wcCJQ7zreAc/M0zvtRhySpRYaGmoEJDVGSfRg4kxXHK1wBfC1P4wXtVQVRkm0NHE8ZZtaknLr4JvB3eRo/32ZtkqQeMjTUtB4aqj/K5wAfrRbdCpyYp/Ht7VVVFyXZRsAxwHHAusCvgFOB8/I0frXN2iRJPWBoqGktNFQHOR4LnEb5H/xC4K+A7w3y9ROiJNsA+ApwNOV1Lp4AvkR5wOR4m7VJkrrI0FDTSmiIkiwCLgI+CCwBTgbOHKazFKIk2wo4nfKsC4BbgCPzNH6wvaokSV1jaKjpa2iIkiwAn6OcjlgHuBc4LE/je/pWRJdFSbYb5dkV2wOLKQ/iPH2YApAkaRKGhpq+3XsiSrI3AdcCFwLzKacldhnmwACQp/HNwM6UUyvjwFeBH0dJ9t5WC5Mkqcv6MtIQJdl2wNWU11x4BDg8T+Pbev6D+yxKsi0pryWxB+V9L74OfClP41daLUyStPocaajp+UhDlGSfAW6jDAzfBXYaxcAAkKfxo5T3wjgC+CXw58CdUZJt32phkiR1QU9HGqIkOws4gXLY/svAGYN8ZkQ3RUm2CXAx8GHKYx1OAs72DAtJGhKONNT0OjQUwAvAp/M0vrFnP2hAVaeVfoHyLIs1KO+XcXiexk+1WpgkadUMDTW9np74CeV0xIwLDAB5Go/naXwe5YGS91HezvveKMk+0W5lkiStvl6Hhg94nwbI0/g+YBfgbOBNwDVRkp0dJdncdiuTJKm51i8jPdNESbYvcAnwW8AdwB/mafx4u1VJkmqcnqjp23UaVMrT+DpgB8ozSnYFflIFCUmSBpojDS2JkmwO5QWuTqwWnQGclKfx0vaqkiS9xpGGGkNDy6qDIi8G1gduojzT5LlWi5IkGRom4fREy/I0vhbYCbiH8kqSXoJakjSQHGkYEFGSrQWcDxxOeefP44B/nCkXw5KkgeNIQ40jDQMiT+OXgc8CR1WL/gG4pAoTkiS1zpGGARQl2a7AVcCmlLcP/1SexgvbrUqSZhhHGmocaRhAeRrfAexIednp7YC7oiTbr92qJEkznSMNAyxKsjHga0BSLToFODlP42XtVSVJM4QjDTWGhiEQJdknKa8iuS5wA/BHeRr/vN2qJGnEGRpqnJ4YAnkaX0N506sFwN6U0xU7tVuVJGmmMTQMiTyNH6a87PTlwObAf0VJdkS7VUmSZhKnJ4ZMlGQB+AJwFjAGXAh8IU/jV1stTJJGjdMTNYaGIRUl2QeAK4GNgbuAA7xbpiR1kaGhxumJIZWn8S2Up2XeTHkZ6h9HSfaRdquSJI0yRxqGXHW3zNOB44EC+Apwap7G460WJknDzpGGGkPDiIiS7GDg28B84Drg0DyNF7VblSQNMUNDjdMTIyJP4+8AuwAPAfsCd0ZJ9p52q5IkjRJDwwjJ0/gByuDwPeAdwG1Rkh3ablWSpFHh9MQIqk7L/CKQUgbD84Hj8zRe3GphkjRMnJ6oMTSMsCjJ9gCuADYEbgcOytP4qXarkqQhYWiocXpihOVpfBPlaZm3A++lPC1zj3arkiQNK0caZoAoyeYCZwPHAOPA3wCne7dMSVoJRxpqDA0zSHVQ5AXAPOAm4DCnKyTpDRgaapyemEHyNL6M8uqR9wB7APdESbZ/u1VJkoaFIw0zUJRkawKnAcdViy4ATsjT+OX2qpKkAeNIQ42hYQaLkuxjwMWUZ1c8SDld8T+tFiVJg8LQUGNomOGiJNsYuAjYB1gGnAqc4jUdJM14hoYaj2mY4fI0fhb4GHAU8CrlmRV3REn27lYLkyQNHEca9JooybagHHX4A2AJ5R0zz8zTeGmrhUlSGxxpqHGkQa/J0/gxyrMqjqecqjiNctRhp1YLkyQNBEcaNKkoybYBLgTeT3lBqHOBv83T+MWVfqEkjQpHGmocadCk8jR+kHKa4mjKD80JwP3VGReSpBnIkQatUpRkmwBfBw6oFl0FfDFP48fbq0qSesyRhhpDgxqLkuwTwDeATSnPtDgdOMOLQkkaSYaGGkODVkuUZPOBBPgLYA3gCeCLwFV5GrszSRodhoYaQ4OmJEqytwNnAp+qFv0I+Ms8je9orypJ6iJDQ42hQdMSJdlewHnAttWia4GT8jRe0F5VktQFhoYaQ4OmLUqyMeAw4GTgbUABXEZ5imbeXmWSNA2GhhpDg7qmunvmUcBJwAaUV5W8iPJgyYVt1iZJq83QUGNoUNdFSbYO5VUlTwTWpbw41BVAmqfxvW3WJkmNGRpqDA3qmSjJ1gc+TxkgNqgWXwecAdzi2RaSBpqhocbQoJ6Lkmwt4AjK0zTfVi2+l/KaD/+Sp/GM/yBKGkCGhhpDg/omSrK5wGeAY4Edq8W/pDzu4fw8jR9pqzZJqjE01Bga1HdRkgVgV+DPgIOBOdVbtwCXAlfmabyopfIkqWRoqDE0qFVRkr0Z+GPK6Yu3V4t/A/wrZYC4IU/jxS2VJ2kmMzTUGBo0EKrRh/dTXu/hYGC96q1fAhlwNXC9t+aW1DeGhhpDgwZOlGTzgP2AQ4C9Ke9xAeUIxI2UoxA3euEoST1laKgxNGigRUm2NvARYH9gX1aMQAA8Cvygaj/M0/gX/a9Q0sgyNNQYGjQ0qrMvdgf2AT4EbNfxdgEsAG7raA95LQhJU2ZoqDE0aGhVB1HuRRkg9gQ2n7DKL4C7gHs62oMeWCmpEUNDjaFBIyNKsrcA7+tov8eK4yGWWwI81NEe7mgvODIh6TWGhhpDg0ZWNZ2xDfCeCW3DN/iSF4HHgSeqx8eBp4HnOtrzjlRIM4ShocbQoBmlOrVzA+CdwFbA1tXjVpTTG+s0+DaLeH2QWN4WUZ4i+quOx87nLzmSIQ0RQ0ONoUHqUN1kazPKALE5sDGw0SStSbiYaJwyPPwaeAl4GXilenx5NV//Bli8qsc8jZdOoU5JYGiYhKFBmoLqWhIb8vogsT7lrcDXW8XjVALHVI2zIkSsKmgsAZZVbbzj+cTXb/TeOBAmtFmTLFtZm119zewJz9tcFibZzuWPTZYtA5ZW/bukxeer+zXL3mhkrBqxW/77bdLGKC8XP7aS56t6v+9ft9biV+Y+cM5BbwV41/FXPvvy3HlLef2+v/x3O3HZZOu8yorP4WTPV/Z+Z3tlkudL+jWKaWiQ+ixKslnAmsBawLzqcXWfrwHMneLjrN5v5cDr/OM+WSDofA71YDFrJctGqX+XVg3qQWrkzVv8avG/5xwYAH7n+KuWvjJ3zdkM5raPMyFI5Gm8ZS9+kKFBmmGiJJvN5GFiDvX/tGevZNlkr4uONj7hdZO2spGNbi0revlfWcd/4cv7pPM/2DlD+HyMFb/PztGUpq3g9SMYSxs+X511p/p1K30/P33feUyYnqh+v8v3+THqn5PJ2hjlZ2zNCY9v9Hziss42b5LnnY/zgJCncU/CjaFBkqTJDOExDVWomdOrs7wMDT0UQlgAUBTFtm3XMsjsp1Wzj5qxn1bNPmrGfprcKM29SZKkHjI0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGPOVSkiQ14kiDJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNExRCOGDIYQFIYRHQwgXhhBmT7LOwSGEh0MIC0MIf9+x/KMhhLtDCEtDCIf0t/L+mmY/nRFCeDCEcE8I4cYQwub9rb4/ptlHx4QQ7q32pztDCLv3t/r+mU4/dbz/3hDCslH93E1zXzo5hPDTal+6O4RwUn+r75/p7kshhM+GEB4IIdwfQrihf5UPgKIobKvZKMPWo8C7qtffAQ6fsM56wBPAW4Ax4FZg9+q9LYHfBS4FDml7ewa4n/YB5lTPjwaubnubBrCP1u1Yb3sgb3ubBrGfqvfnAj8CslH83HVhXzoZ+Ou2t2MI+ul9wG3LP3vAxm1vUz+bIw1TszPwTFEUD1SvvwUcMGGdfYD/KIrip0VRLAUuWb5OURSPFkVxPzDer4JbMt1+ur4oiiXVencAm/Wh5n6bbh/9qmO9+cCoXq1tWv1U+TJwMfB8j2ttSzf6aCaYbj8dC6TLP3tFUTzbh5oHhqFhajYFnux4/QTwtimsM+q62U9/Cny/q9UNhmn3UTVU+jDwb8ChPaqzbdPqpxDCtsDvAxf1sMa2dePz9ifVdNfVIYR39qbM1k23n7YBdgwh3BpC+O8QwoE9q3QAGRqmJnRpnVHXlX4KIRwJ7ACcOu2KBs+0+6goiouKotgKOAT4aleqGjxT7qcQwizgfODYohpPHlHT3Ze+CbyjKIrtgMspQ+gomm4/jQGbA7sB+wNnhRC26EZhw8DQMDVP8vpkuhnw1BTWGXXT7qcQwgHAcUBcFMUrPaqzTV3bl4qi+D7w7hDCm7pd5ACYTj+tA2wLXB9CyIEDgXNCCJ/rWbXtmNa+VBTFs8unA4uiuAJYP4Tw270rtzXT/cw9CXy3KIplRVE8TTl1ul2Pah08bR9UMYwNmA08xusPpPnshHXWo9y5Og+k2WPCOhczggdkdaufgA8BjwCbtb0tA9xHW3estxvwVNvbNIj9NGG9kfzcdWFf2qRjvT2q9ULb2zWA/fQ54NyO9RZ2fg5HvbVewLA2YE/ggWqH+Xa1Y30cuLBjnU9Xf/QWAqd1LN+LMrW+BLxQPV+j7W0awH56BHgauLtqP2h7ewawj74BLKj65xZgl7a3ZxD7acL3GcnQ0IV96VLgvmpfuhnYue3tGdB+GgP+ufrc3Q8c2fb29LN5a2xJktSIxzRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIa+X+jLlEz6C0qBAAAAABJRU5ErkJggg=="></button><div class="modal fade" id="plot_SSuJIUqgoTgtQyRBuapSICiQ0BYFRhIh" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0407010P0AAABAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Nefopam 30mg tablets : 12306</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where Northamptonshire STP is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0704020AA&amp;denomIds=7.4.2&amp;selectedTab=summary">Duloxetine hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>702</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>42012</td>
      <td>0.02</td>
      <td>0.04</td>
      <td>0.01</td>
      <td>-3.37</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_xQV8omBUxIVh0eMCSmSzAA0IAkE9DooY"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_xQV8omBUxIVh0eMCSmSzAA0IAkE9DooY" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0704020AAAAAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Duloxetine 20mg gastro-resistant capsules : 399</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0704020AAAAABAB&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Duloxetine 40mg gastro-resistant capsules : 296</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0704020AABBAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Yentreve 20mg gastro-resistant capsules : 7</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>36</td>
      <td>Preparations for warts and calluses</td>
      <td>240</td>
      <td>0.15</td>
      <td>0.65</td>
      <td>0.17</td>
      <td>-2.91</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ap3ROmPd2mmtOm1HxBuIircKuqIiWq0B"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ap3ROmPd2mmtOm1HxBuIircKuqIiWq0B" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AAAEAE&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 50% ointment : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AAAVAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 12% / Lactic acid 4% gel : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AAAWAW&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 16.7% / Lactic acid 16.7% paint : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AABABA&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 26% solution : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AABMBM&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 26% gel : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0AABYBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 16.7% / Lactic acid 15% paint : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0BFAAAE&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Verrugon complete 50% ointment : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0BJAAAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salatac gel : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0BKABBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Duofilm paint : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0BXAAAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Bazuka gel : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1307000M0BXACAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Bazuka Treatment gel : 1</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0&amp;denomIds=1.6.1&amp;selectedTab=summary">Ispaghula husk</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>7936</td>
      <td>Bulk-forming laxatives</td>
      <td>9051</td>
      <td>0.88</td>
      <td>0.96</td>
      <td>0.03</td>
      <td>-2.72</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_M4vihkZxQ8bhcEQcB3EcRHDUOAgoMCKu"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_M4vihkZxQ8bhcEQcB3EcRHDUOAgoMCKu" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0AAADAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispaghula husk 3.5g efferv gran sach gluten free sugar free : 3201</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0AAATAT&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispaghula husk 3.5g granules sachets gluten free : 80</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BBAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel 3.5g effervescent granules sachets plain SF : 681</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BBABAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Orange 3.5g effervescent granules sachets SF : 3128</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BBACAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Lemon 3.5g effervescent granules sachets SF : 616</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BJAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispagel Orange 3.5g effervescent granules sachets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BKAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Hi-Fibre Orange 3.5g effervescent granules sachets : 180</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0106010E0BKABAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Hi-Fibre Lemon 3.5g effervescent granules sachets : 42</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>99545</td>
      <td>Vitamin D</td>
      <td>105505</td>
      <td>0.94</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.48</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_omhh1FUBU16IEkWCLhg0aJCISihUJECi"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_omhh1FUBU16IEkWCLhg0aJCISihUJECi" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 3765</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 183</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 137</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 234</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 190</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 869</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 1954</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 385</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 392</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 694</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 121</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 86</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 138</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 99</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 84</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 61</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 59</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 344</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEPEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 208</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAERER&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit chewable tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 51</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 7364</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 312</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 7075</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 1332</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 1589</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 13686</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 71</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 1069</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 471</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 866</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BRACCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 500mg/400unit caplets : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 69</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 102</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAFCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 5,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 35</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWALBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWASEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000units/ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAUAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BWAYEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit Vegan tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 3799</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 220</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0BZAACI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">DLux 400 oral spray : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHAAEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 400unit tablets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHACCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,200unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHADAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHAFCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 10,000unit tablets : 63</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHAIEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 50,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHAJDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000units/ml liquid : 41</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 100</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 77</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 41227</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DCABDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 Lemon Melts 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DDAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kora LiquiD 3000units/ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 1184</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 593</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 1686</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 1605</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 398</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DGAADI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">TheiCal-D3 1000mg/880unit chewable tablets : 1296</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 2336</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1311040K0&amp;denomIds=13.11.4&amp;selectedTab=summary">Iodine compounds</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Chlorine and iodine</td>
      <td>5</td>
      <td>0.60</td>
      <td>0.94</td>
      <td>0.14</td>
      <td>-2.45</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_WyrURXFoh9aeEbHQSkdaGKSAtA12xJll"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_WyrURXFoh9aeEbHQSkdaGKSAtA12xJll" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=stp&amp;orgIds=E54000020&amp;numIds=1311040K0AAATAT&amp;denomIds=13.11.4&amp;selectedTab=summary" target="_blank">Povidone-Iodine 10% antiseptic solution : 3</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>